bioAffinity Technologies, Inc. (BIAF) vs Nuwellis, Inc. (NUWE)
A side-by-side comparison of bioAffinity Technologies, Inc. and Nuwellis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NUWE
Nuwellis, Inc.
$0.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BIAF vs NUWE
growth of $100 · dividends reinvested · last 1yBIAF -82.4% (-82.4%/yr)NUWE -98.5% (-98.5%/yr)BIAF compounded faster over this window
Log scale — wide-divergence pair
BIAF NUWE
BIAF vs NUWE: by the numbers
- •NUWE is the larger company ($3M vs $3M market cap).
- •Both run net losses; NUWE's is the smaller (-123.38% vs -257.33% net margin).
Metrics side by side
Valuation
| Metric | BIAF | NUWE |
|---|---|---|
| P/S ratio | 0.43 | 0.28 |
| P/B ratio | 0.67 | N/A |
Profitability
| Metric | BIAF | NUWE |
|---|---|---|
| Gross margin | 23.21% | 69.69% |
| Operating margin | -171.58% | -140.62% |
| Net margin | -257.33% | -123.38% |
| ROE | -402.92% | N/A |
| ROIC | -237.93% | -238.32% |
Growth (annualized)
| Metric | BIAF | NUWE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.48% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.